Guillain-Barre syndrome associated with Zika virus infection

Genetic and Serologic Properties of Zika Virus Associated with an Epidemic, Yap State, Micronesia, 2007

Lanciotti, R. S., Kosoy, O. L., Laven, J. J., Velez, J. O., Lambert, A. J., Johnson, A. J., Stanfield, S. M., & Duffy, M. R. (2008) · Emerging infectious diseases · doi:10.3201/eid1408.080287 · Cited by 2,173

Zika virus infection complicated by Guillain-Barré syndrome – case report, French Polynesia, December 2013

Oehler, E., Watrin, L., Larre, P., Leparc-Goffart, I., Lastère, S., Valour, F., Baudouin, L., Mallet, H., Musso, D., & Ghawche, F. (2014) · Eurosurveillance · doi:10.2807/1560-7917.es2014.19.9.20720 · Cited by 1,046

Guillain–Barré syndrome and Fisher syndrome: Case definitions and guidelines for collection, analysis, and presentation of immunization safety data

Sejvar, J. J., Kohl, K. S., Gidudu, J., Amato, A. A., Bakshi, N., Baxter, R. P., Burwen, D. R., Cornblath, D. R., Cleerbout, J., Edwards, K. M., et al. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.06.003 · Cited by 651

Neurological manifestations of dengue infection

Solomon, T., Dung, N. M., Vaughn, D. W., Kneen, R., Thao, L. T. T., Raengsakulrach, B., Loan, H. T., Day, N., Farrar, J., Myint, K. S. A., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02036-5 · Cited by 635

Zika virus: following the path of dengue and chikungunya?

Musso, D., Cao‐Lormeau, V., & Gubler, D. J. (2015) · The Lancet · doi:10.1016/s0140-6736(15)61273-9 · Cited by 403

Zika virus: following the path of dengue and chikungunya?

Isl, M., States, F. M., Isl, S., Isl, F., Isl, N., & Isl, T. C. (2015) · Cited by 328

Zika virus as a causative agent for primary microencephaly: the evidence so far

Tang, B. L. (2016) · Archives of Microbiology · doi:10.1007/s00203-016-1268-7 · Cited by 34

An update on the aspects of Zika virus infection on male reproductive system

Borges, E. D. R., Vireque, A. A., Berteli, T. S., Ferreira, C. R., da Silva, A. S., & Navarro, P. A. (2019) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-019-01493-y · Cited by 34

Zika virus NS5 nuclear accumulation is protective of protein degradation and is required for viral RNA replication

Ji, W., & Luo, G. G. (2019) · Virology · doi:10.1016/j.virol.2019.10.010 · Cited by 34

Continuing development of vaccines and monoclonal antibodies against Zika virus

Woodson, S. E., & Morabito, K. M. (2024) · npj Vaccines · doi:10.1038/s41541-024-00889-x · Cited by 33

Zika virus-induced acute myelitis and motor deficits in adult interferon αβ/γ receptor knockout mice

Zukor, K., Wang, H., Siddharthan, V., Julander, J. G., & Morrey, J. D. (2018) · Journal of NeuroVirology · doi:10.1007/s13365-017-0595-z · Cited by 33

Comparative Pathogenesis of Asian and African-Lineage Zika Virus in Indian Rhesus Macaque’s and Development of a Non-Human Primate Model Suitable for the Evaluation of New Drugs and Vaccines

Rayner, J. O., Kalkeri, R., Goebel, S. J., Cai, Z., Green, B., Lin, S., Snyder, B. A., Hagelin, K., Walters, K., & Koide, F. (2018) · Viruses · doi:10.3390/v10050229 · Cited by 33

Zika virus and autoimmunity. One-step forward

Monsalve, D. M., Pacheco, Y., Acosta‐Ampudia, Y., Rodríguez, Y., Ramı́rez-Santana, C., & Anaya, J. (2017) · Autoimmunity Reviews · doi:10.1016/j.autrev.2017.10.008 · Cited by 32

High susceptibility, viral dynamics and persistence of South American Zika virus in New World monkey species

Berry, N. J., Ferguson, D., Ham, C., Hall, J., Jenkins, A., Giles, E., Devshi, D., Kempster, S. L., Rose, N. J., Dowall, S., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-50918-2 · Cited by 32

Off the Podium: Why Public Health Concerns for Global Spread of Zika Virus Means That Rio de Janeiro’s 2016 Olympic Games Must Not Proceed

Attaran, A. (2016) · doi:10.54111/0001/j1 · Cited by 32

A review of Zika virus infections in pregnancy and implications for antenatal care in Singapore

Lin, H., Tambyah, P. A., Yong, E., Biswas, A., & Chan, S. (2017) · Singapore Medical Journal · doi:10.11622/smedj.2017026 · Cited by 32

Zika virus NS2B/NS3 proteinase: A new target for an old drug - Suramin a lead compound for NS2B/NS3 proteinase inhibition-

Coronado, M. A., Eberle, R. J., Bleffert, N., Feuerstein, S., Olivier, D. S., de Moraes, F. R., Willbold, D., & Arni, R. K. (2018) · Antiviral Research · doi:10.1016/j.antiviral.2018.10.019 · Cited by 32

Inactivation of Zika virus in human breast milk by prolonged storage or pasteurization

Pfaender, S., Vielle, N. J., Ebert, N., Steinmann, E., Alves, M. P., & Thiel, V. (2016) · Virus Research · doi:10.1016/j.virusres.2016.11.025 · Cited by 31

Zika Virus as an Emerging Neuropathogen: Mechanisms of Neurovirulence and Neuro-Immune Interactions

Morris, G., Barichello, T., Stubbs, B., Köhler, C. A., Carvalho, A. F., & Maes, M. H. J. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0635-y · Cited by 31

Zika Virus: Recent Advances towards the Development of Vaccines and Therapeutics

McArthur, M. A. (2017) · Viruses · doi:10.3390/v9060143 · Cited by 31

Testicular immunity

Li, S., Kumar, S., Gu, X., & DeFalco, T. (2024) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2024.101323 · Cited by 30

Evolution of the innate and adaptive immune response in women with acute Zika virus infection

Tonnerre, P., Melgaço, J. G., Torres-Cornejo, A., Pinto, M. A., Yue, C., Blümel, J., de Sousa, P. S. F., Mello, V. M., Moran, J., de Filippis, A. M. B., et al. (2019) · Nature Microbiology · doi:10.1038/s41564-019-0618-z · Cited by 30

Cross-Reactive Antibodies during Zika Virus Infection: Protection, Pathogenesis, and Placental Seeding

Zimmerman, M. G., Wrammert, J., & Suthar, M. S. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2019.12.003 · Cited by 29

A direct-acting antiviral drug abrogates viremia in Zika virus–infected rhesus macaques

Lim, S., Osuna, C. E., Best, K., Taylor, R., Chen, E., Yoon, G., Kublin, J. L., Schalk, D. R., SCHULTZ‐DARKEN, N. J., Capuano, S., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aau9135 · Cited by 29

Antiviral activity of glycyrrhizic acid conjugates with amino acid esters against Zika virus

Балтина, Л. А., Hour, M., Liu, Y.-C., Chang, Y.-S., Huang, S.-H., Lai, H., Кондратенко, Р. М., Petrova, S. F., Yunusov, M. S., & Lin, C. (2020) · Virus Research · doi:10.1016/j.virusres.2020.198290 · Cited by 29

Overview of COVID-19 and neurological complications

Hosseini, N., Nadjafi, S., & Ashtari, B. (2021) · Reviews in the Neurosciences · doi:10.1515/revneuro-2020-0116 · Cited by 29

An Integrative Analysis Reveals a Central Role of P53 Activation via MDM2 in Zika Virus Infection Induced Cell Death

Teng, Y., Liu, S., Guo, X., Liu, S., Jin, Y., He, T., Bi, D., Zhang, P., Lin, B., An, X., et al. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00327 · Cited by 28

The re‐emerging arboviral threat: Hidden enemies

Dutra, H. L. C., Caragata, E. P., & Moreira, L. A. (2016) · BioEssays · doi:10.1002/bies.201600175 · Cited by 28

Nervous System Injury and Neuroimaging of Zika Virus Infection

Wu, S., Zeng, Y., Lerner, A., Gao, B., & Law, M. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00227 · Cited by 28

Zika Virus

Relich, R. F., & Loeffelholz, M. J. (2017) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2017.01.002 · Cited by 28

Pyrethroid resistance in Aedes aegypti: genetic mechanisms worldwide, and recommendations for effective vector control

Hernandez, J. R., & Pietrantonio, P. V. (2025) · Parasites & Vectors · doi:10.1186/s13071-025-07010-8 · Cited by 27

A Gorilla Adenovirus-Based Vaccine against Zika Virus Induces Durable Immunity and Confers Protection in Pregnancy

Hassan, A. O., Dmitriev, I. P., Kashentseva, E. A., Zhao, H., Brough, D. E., Fremont, D. H., Curiel, D. T., & Diamond, M. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.08.005 · Cited by 27

Zika Virus Disease and Associated Neurologic Complications

Duca, L. M., Beckham, J. D., Tyler, K. L., & Pastula, D. M. (2017) · Current Infectious Disease Reports · doi:10.1007/s11908-017-0557-x · Cited by 26

Profile likelihood-based analyses of infectious disease models

Tönsing, C., Timmer, J., & Kreutz, C. (2018) · Statistical Methods in Medical Research · doi:10.1177/0962280217746444 · Cited by 26

Zika Virus-Specific IgY Results Are Therapeutic Following a Lethal Zika Virus Challenge without Inducing Antibody-Dependent Enhancement

O’Donnell, K. L., Meberg, B. M., Schiltz, J., Nilles, M. L., & Bradley, D. S. (2019) · Viruses · doi:10.3390/v11030301 · Cited by 26

Inflammation markers in the saliva of infants born from Zika-infected mothers: exploring potential mechanisms of microcephaly during fetal development

de Oliveira, D. N., Lima, E. D. O., Melo, C. F. O. R., Delafiori, J., Guerreiro, T. M., Rodrigues, R. G. M., Morishita, K. N., Silveira, C., Muraro, S. P., de Souza, G. F., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-49796-5 · Cited by 26

Zika virus depletes neural stem cells and evades selective autophagy by suppressing the Fanconi anemia protein FANCC

Tiwari, S. K., Dang, J. W., Lin, N., Qin, Y., Wang, S., & Rana, T. M. (2020) · EMBO Reports · doi:10.15252/embr.201949183 · Cited by 26

Structural Basis for Neutralization and Protection by a Zika Virus-Specific Human Antibody

Wang, L., Wang, R., Wang, L., Ben, H., Yu, L., Gao, F., Shi, X., Yin, C., Zhang, F., Xiang, Y., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.02.062 · Cited by 26

Supporting local health decision making with spatial video: Dengue, Chikungunya and Zika risks in a data poor, informal community in Nicaragua

Curtis, A., Quinn, M., Obenauer, J., & Renk, B. M. (2017) · Applied Geography · doi:10.1016/j.apgeog.2017.08.008 · Cited by 25

Structure and Dynamics of Zika Virus Protease and Its Insights into Inhibitor Design

Li, Q., & Kang, C. (2021) · Biomedicines · doi:10.3390/biomedicines9081044 · Cited by 25

Zika Virus–Associated Guillain-Barré Syndrome in a Returning US Traveler

Beattie, J., Parajuli, S., Sanger, M., Lee, G., Pleninger, P., Crowley, G., Kwon, S., Murthy, V., Manko, J. A., Caplan, A. L., et al. (2018) · Infectious Diseases in Clinical Practice · doi:10.1097/ipc.0000000000000654 · Cited by 25

Zika Virus Pathogenesis: From Early Case Reports to Epidemics

Pardy, R. D., & Richer, M. J. (2019) · Viruses · doi:10.3390/v11100886 · Cited by 25

Flexible Synthetic Carbohydrate Receptors as Inhibitors of Viral Attachment

Bravo, M. F., Lema, M. A., Marianski, M., & Braunschweig, A. B. (2020) · Biochemistry · doi:10.1021/acs.biochem.0c00732 · Cited by 25

Zika Virus as Oncolytic Therapy for Brain Cancer: Myth or Reality?

Su, K.-Y., & Balasubramaniam, V. R. M. T. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.02715 · Cited by 24

Clinical, Virological, and Immunological Profiles of DENV, ZIKV, and/or CHIKV-Infected Brazilian Patients

Sánchez‐Arcila, J. C., Badolato-Corrêa, J., de Souza, T. M. A., Paiva, I. A., Barbosa, L. S., Nunes, P. C. G., Lima, M. D. R. Q., dos Santos, F. B., Damasco, P. V., da Cunha, R. V., et al. (2020) · Intervirology · doi:10.1159/000510223 · Cited by 23

Zika virus infection as a cause of congenital brain abnormalities and Guillain-Barré syndrome: systematic reviewPreprint

Krauer, F., Riesen, M., Revéiz, L., Oladapo, O. T., Martínez-Vega, R. A., Porgo, T. V., Haefliger, A., Broutet, N. J. N., Low, N. N., & for the WHO Zika Causality Working Group (2016) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/073098 · Cited by 23

Zika virus shedding in the stool and infection through the anorectal mucosa in mice

Li, C., Deng, Y., Zu, S., Quanquin, N. M., Shang, J., Tian, M., Ji, X., Zhang, N., Dong, H.-L., Xu, Y., et al. (2018) · Emerging Microbes & Infections · doi:10.1038/s41426-018-0170-6 · Cited by 22

Human DDX3X Unwinds Japanese Encephalitis and Zika Viral 5′ Terminal Regions

Nelson, C. R., Mrozowich, T., Gemmill, D. L., Park, S. M., & Patel, T. R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22010413 · Cited by 22

Circle-to-circle amplification coupled with microfluidic affinity chromatography enrichment for in vitro molecular diagnostics of Zika fever and analysis of anti-flaviviral drug efficacy

Soares, R. R. G., Pettke, A., Robles-Remacho, A., Zeebaree, S., Ciftci, S., Tampere, M., Russom, A., Puumalainen, M.-R., Nilsson, M. F., & Madaboosi, N. (2021) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2021.129723 · Cited by 22

The Zika virus disease: An overview

Galán-Huerta, K. A., Rivas-Estilla, A. M., Martínez-Landeros, E. A., Arellanos-Soto, D., & Ramos‐Jiménez, J. (2016) · Medicina Universitaria · doi:10.1016/j.rmu.2016.05.003 · Cited by 22

Identification of novel small-molecule inhibitors of Zika virus infection

Micewicz, E. D., Khachatoorian, R., French, S. W., & Ruchala, P. P. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2017.12.019 · Cited by 21

Geospatial modeling of microcephaly and zika virus spread patterns in Brazil

Amaral, P., de Carvalho, L. R., Rocha, T. A. H., da Silva, N. C., & Vissoci, J. R. N. (2019) · PLoS ONE · doi:10.1371/journal.pone.0222668 · Cited by 21

Viral and Prion Infections Associated with Central Nervous System Syndromes in Brazil

Junior, I. P. D. S., dos Santos, F. B., de Paula, V. S., Vieira, T. C. R. G., Dias, H. G., Barros, C. A., & da Silva, E. E. (2021) · Viruses · doi:10.3390/v13071370 · Cited by 22

The discovery of Zika virus NS2B-NS3 inhibitors with antiviral activity via an integrated virtual screening approach

Mirza, M. U., Alanko, I., Vanmeert, M., Muzzarelli, K. M., Salo‐Ahen, O. M. H., Abdullah, I., Kovari, I. A., Claes, S., Jonghe, S. D., Schols, D., et al. (2022) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2022.106220 · Cited by 21

A Comprehensive Systems Biology Approach to Studying Zika Virus

May, M. A., & Relich, R. F. (2016) · PLoS ONE · doi:10.1371/journal.pone.0161355 · Cited by 21

Anti-Zika Activity of a Library of Synthetic Carbohydrate Receptors

Palanichamy, K., Joshi, A., Mehmetoglu-Gurbuz, T., Bravo, M. F., Shlain, M. A., Schiro, F., Naeem, Y., Garg, H., & Braunschweig, A. B. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00142 · Cited by 21

Development of Therapeutic Monoclonal Antibodies for Emerging Arbovirus Infections

Ormundo, L. F., Barreto, C. T., & Tsuruta, L. R. (2023) · Viruses · doi:10.3390/v15112177 · Cited by 20

Zika Virus—A Reemerging Neurotropic Arbovirus Associated with Adverse Pregnancy Outcomes and Neuropathogenesis

Elliott, K. C., & Mattapallil, J. J. (2024) · Pathogens · doi:10.3390/pathogens13020177 · Cited by 20

A Peptide-Based Virus Inactivator Protects Male Mice Against Zika Virus-Induced Damage of Testicular Tissue

Si, L., Meng, Y., Tian, F., Li, W., Zou, P., Wang, Q., Xu, W., Wang, Y., Xia, M., Hu, J., et al. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.02250 · Cited by 20

Assessing the risk of spread of Zika virus under current and future climate scenarios

Xu, Y., Zhou, J., Liu, T., Liu, P., Wu, Y., Lai, Z., Gu, J., & Chen, X. (2022) · Biosafety and Health · doi:10.1016/j.bsheal.2022.03.012 · Cited by 20

Incorporation of IgG Depletion in a Neutralization Assay Facilitates Differential Diagnosis of Zika and Dengue in Secondary Flavivirus Infection Cases

Calvert, A. E., Boroughs, K. L., Laven, J. J., Stovall, J. L., Luy, B. E., Kosoy, O. I., & Huang, C. Y. ‐. (2018) · Journal of Clinical Microbiology · doi:10.1128/jcm.00234-18 · Cited by 20

Diversity of Medicinal Plants Used in the Treatment and Management of Viral Diseases Transmitted by Mosquitoes in the Tropics

Abajue, M. C., Sawyer, W. E., Izah, S. C., & Ogwu, M. C. (2023) · Reference series in phytochemistry · doi:10.1007/978-3-031-21973-3_60-1 · Cited by 18

Immunogenicity and Efficacy of a Recombinant Human Adenovirus Type 5 Vaccine against Zika Virus

Steffen, T. L., Hassert, M., Hoft, S. G., Stone, E. T., Zhang, J., Geerling, E., Grimberg, B. T., Roberts, M. S., Pinto, A. K., & Brien, J. D. (2020) · Vaccines · doi:10.3390/vaccines8020170 · Cited by 18

Pre-existing Immunity to Japanese Encephalitis Virus Alters CD4 T Cell Responses to Zika Virus Inactivated Vaccine

Lima, N. S., Moon, D., Darko, S. W., Barrera, R. A. D. L., Lin, L., Koren, M. A., Jarman, R. G., Eckels, K. H., Thomas, S. J., Michael, N. L., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.640190 · Cited by 18

Development and validation of a one-step reverse transcription loop-mediated isothermal amplification (RT-LAMP) for rapid detection of ZIKV in patient samples from Brazil

da Silva, S. J. R., Pardee, K., Balasuriya, U. B. R., & Pena, L. (2021) · Scientific Reports · doi:10.1038/s41598-021-83371-1 · Cited by 18

Expression, purification of Zika virus membrane protein-NS2B in detergent micelles for NMR studies

Ng, E. Y., Loh, Y. R., Li, Y., Li, Q., & Kang, C. (2018) · Protein Expression and Purification · doi:10.1016/j.pep.2018.09.013 · Cited by 18

Human Testicular Germ Cells, a Reservoir for Zika Virus, Lack Antiviral Response Upon Zika or Poly(I:C) Exposure

Kuassivi, N. O., Abiven, H., Satié, A.-P., Cartron, M., Mahé, D., Aubry, F., Mathiéu, R., Rebours, V., Tortorec, A. L., & Dejucq‐Rainsford, N. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.909341 · Cited by 17

Zika Virus Infection Associated With Congenital Birth Defects in a HIV-infected Pregnant Woman

Joao, E. C., Gouvêa, M. I. F. D. S., Teixeira, M. D. L. B., Mendes‐Silva, W., Esteves, J. S., Santos, E. M., Ledesma, L. A., Gomes, A. P., & Cruz, M. L. S. (2016) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000001482 · Cited by 16

Discovery of dehydroandrographolide derivatives with C19 hindered ether as potent anti-ZIKV agents with inhibitory activities to MTase of ZIKV NS5

Qian, W., Zhou, G., Ge, X., Xue, J.-X., Zheng, C., Yang, L., Gu, X.-R., Li, C., Xiong, S., Zheng, Y., et al. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114710 · Cited by 16

Viral tropism for the testis and sexual transmission

Wang, F., Zhang, J., Wang, Y., Chen, Y., & Han, D. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1040172 · Cited by 16

ZIKV Demonstrates Minimal Pathologic Effects and Mosquito Infectivity in Viremic Cynomolgus Macaques

Azar, S. R., Rossi, S. L., Haller, S. L., Yun, R., Huang, J. H., Plante, J. A., Zhou, J., Olano, J. P., Roundy, C. M., Hanley, K. A., et al. (2018) · Viruses · doi:10.3390/v10110661 · Cited by 16

Characterization of two engineered dimeric Zika virus envelope proteins as immunogens for neutralizing antibody selection and vaccine design

Yang, C., Zeng, F., Gao, X., Zhao, S., Li, X., Liu, S., Li, N., Deng, C., Zhang, B., & Gong, R. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.007443 · Cited by 16

Zika virus infection and risk of Guillain-Barré syndrome: A meta-analysis

Bautista, L. E. (2019) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2019.06.019 · Cited by 16

Human Polyclonal Antibodies Prevent Lethal Zika Virus Infection in Mice

Branche, E., Simon, A. Y., Sheets, N., Kim, K., Barker, D., Nguyen, A.-V. T., Sahota, H., Young, M. P., Salgado, R., Mamidi, A., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-46291-9 · Cited by 16

Inhibition of zika virus infection by fused tricyclic derivatives of 1,2,4,5-tetrahydroimidazo[1,5-a]quinolin-3(3aH)-one

Xu, B., Lee, E. M., Medina, A., Sun, X., Wang, D., Tang, H., & Zhou, G. (2020) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2020.104205 · Cited by 16

An Overview of Zika Virus and Zika Virus Induced Neuropathies

Wahaab, A., Mustafa, B. E., Hameed, M., Batool, H., Minh, H. T. N., Tawaab, A., Shoaib, A., Wei, J., & Rasgon, J. L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms26010047 · Cited by 15

Intrinsic features of Zika Virus non-structural proteins NS2A and NS4A in the regulation of viral replication

Yu, Y., Gao, C., Wen, C., Zou, P., Qi, X., Cardona, C. J., & Xing, Z. (2022) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0010366 · Cited by 15

Antiviral effects of the fused tricyclic derivatives of indoline and imidazolidinone on ZIKV infection and RdRp activities of ZIKV and DENV

Zhou, G., Li, F., Xue, J.-X., Qian, W., Gu, X.-R., Zheng, C., Li, C., Yang, L., Xiong, S., Zhou, G.-C., et al. (2023) · Virus Research · doi:10.1016/j.virusres.2023.199062 · Cited by 15

Zika Virus-Associated Aseptic Meningitis and Guillain–Barre Syndrome in a Traveler Returning from Latin America: a Case Report and Mini-Review

Wright, J. K., Castellani, L., Lecce, C., Khatib, A. N., Bonta, M., & Boggild, A. K. (2019) · Current Infectious Disease Reports · doi:10.1007/s11908-019-0661-1 · Cited by 15

Structural basis for Zika envelope domain III recognition by a germline version of a recurrent neutralizing antibody

Esswein, S. R., Gristick, H. B., Jurado, A., Peace, A., Keeffe, J. R., Lee, Y. E., Voll, A. V., Saeed, M., Nussenzweig, M. C., Rice, C. M., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1919269117 · Cited by 15

Zika virus disease for neurologists

Smith, D., Beckham, J. D., Tyler, K. L., & Pastula, D. M. (2016) · Neurology Clinical Practice · doi:10.1212/cpj.0000000000000307 · Cited by 14

Diagnosing Zika virus infection against a background of other flaviviruses: Studies in high resolution serological analysis

Hansen, S., Hotop, S., Faye, O., Ndiaye, O., Böhlken-Fascher, S., Pessôa, R., Hufert, F. T., Stahl‐Hennig, C., Frank, R., Czerny, C., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-40224-2 · Cited by 14

Neuropathogenesis of Zika Virus Infection : Potential Roles of Antibody-Mediated Pathology.

Tsunoda, I., Omura, S., Sato, F., Kusunoki, S., Fujita, M., Park, A.-M., Hasanovic, F., Yanagihara, R. T., & Nagata, S. (2016) · PubMed · Cited by 14

Peripheral Neuropathies in Infectious Diseases

Anand, P., Kharal, G. A., Reda, H. M., & Venna, N. (2019) · Seminars in Neurology · doi:10.1055/s-0039-1688995 · Cited by 14

Generation of Zika virus–specific T cells from seropositive and virus-naïve donors for potential use as an autologous or “off-the-shelf” immunotherapeutic

Hanajiri, R., Sani, G. M., Hanley, P. J., Silveira, C. G. T., Kallas, E. G., Keller, M. D., & Bollard, C. M. (2019) · Cytotherapy · doi:10.1016/j.jcyt.2019.06.008 · Cited by 14

A Label and Probe-Free Zika Virus Immunosensor Prussian Blue@carbon Nanotube-Based for Amperometric Detection of the NS2B Protein

Silva, B. V. M., Cordeiro, M. T., Rodrigues, M. A. B., Marques, E. T. A., & Dutra, R. F. (2021) · Biosensors · doi:10.3390/bios11050157 · Cited by 14

Development of the Abbott RealTime ZIKA assay for the qualitative detection of Zika virus RNA from serum, plasma, urine, and whole blood specimens using the m2000 system

Frankel, M. B., Pandya, K., Gersch, J., Siddiqui, S., & Schneider, G. J. (2017) · Journal of Virological Methods · doi:10.1016/j.jviromet.2017.05.002 · Cited by 13

Castanospermine reduces Zika virus infection-associated seizure by inhibiting both the viral load and inflammation in mouse models

Tharappel, A. M., Cheng, Y., Holmes, E. H., Ostrander, G. K., & Tang, H. (2020) · Antiviral Research · doi:10.1016/j.antiviral.2020.104935 · Cited by 13

Epidemiological, virological and clinical characterization of a Dengue/Zika outbreak in the Caribbean region of Costa Rica 2017–2018

Soto-Garita, C., Murillo, T., Chávez-Peraza, I., Campos-Ávila, J., Prado-Hidalgo, G., Drexler, J. F., Moreira‐Soto, A., & Corrales‐Aguilar, E. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1421744 · Cited by 12

Guillian--Barre' Syndrome in Patients with SARS-CoV-2

Dhamne, M. C., Benny, R., Singh, R., Pande, A. U., Agarwal, P. A., Wagh, S., Oak, P., Lakhotia, A. N., Godge, Y., Bolegave, V., et al. (2021) · Annals of Indian Academy of Neurology · doi:10.4103/aian.aian_1303_20 · Cited by 12

Synthesis of 10,10'-Bis(Trifluoromethyl) Marinopyrrole a Derivatives and Evaluation of Their Antiviral Activities in Vitro

Xiao, Y., Yang, J., Zou, L., Wu, P., Li, W., Yan, Y., Li, Y., Li, S., Song, H., Zhong, W., et al. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114436 · Cited by 12

A randomized, placebo-controlled, blinded phase 1 study investigating a novel inactivated, Vero cell-culture derived Zika virus vaccine

Wressnigg, N., Hochreiter, R., Schneider, M., Obersriebnig, M., Bézay, N., Lingnau, K., Ramljak, I. C., Dubischar, K. L., & Eder-Lingelbach, S. (2022) · Journal of Travel Medicine · doi:10.1093/jtm/taac127 · Cited by 12

Protein backbone flexibility pattern is evolutionarily conserved in the Flaviviridae family: A case of NS3 protease in Flavivirus and Hepacivirus

Palanisamy, N., Akaberi, D., & Lennerstrand, J. (2017) · Molecular Phylogenetics and Evolution · doi:10.1016/j.ympev.2017.09.015 · Cited by 12

Current development of Zika virus vaccines with special emphasis on virus-like particle technology

Cimica, V., Galarza, J. M., Rashid, S., & Stedman, T. T. (2021) · Expert Review of Vaccines · doi:10.1080/14760584.2021.1945447 · Cited by 12

Zika Virus Infection of Sertoli Cells Alters Protein Expression Involved in Activated Immune and Antiviral Response Pathways, Carbohydrate Metabolism and Cardiovascular Disease

Rashid, M., Lao, Y., Spicer, V., & Coombs, K. M. (2022) · Viruses · doi:10.3390/v14020377 · Cited by 12

Optimization of 1,3-disubstituted urea-based inhibitors of Zika virus infection

Khachatoorian, R., Micewicz, E. D., Micewicz, A., French, S. W., & Ruchala, P. P. (2019) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2019.126626 · Cited by 12

Zika Virus Infection in the Elderly: Possible Relationship with Guillain-Barré Syndrome

Savino, W., Messias, C. V., Mendes‐da‐Cruz, D. A., Passos, P., Ferreira, A. C. A. F., & Nascimento, O. J. M. (2016) · Gerontology · doi:10.1159/000453579 · Cited by 11

Discovery of ZFD-10 of a pyridazino[4,5-b]indol-4(5H)-one derivative as an anti-ZIKV agent and a ZIKV NS5 RdRp inhibitor

Zhou, G., Qian, W., Li, F., Yang, R., Yang, R., Zheng, C.-B., Chun-yan, L., Gu, X.-R., Yang, L., Liu, J., et al. (2023) · Antiviral Research · doi:10.1016/j.antiviral.2023.105607 · Cited by 11

Rapid Neutralization Testing System for Zika Virus Based on an Enzyme-Linked Immunospot Assay

Li, S., Zhao, H., Yang, H.-W., Hou, W., Cruz‐Cosme, R., Cao, R., Chen, C.-Y., Wang, W., Xu, L., Zhang, J., et al. (2019) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.9b00333 · Cited by 10

Evaluating Known Zika Virus NS2B-NS3 Protease Inhibitor Scaffolds via In Silico Screening and Biochemical Assays

Santos, L. H., Rocha, R. E. O., Dias, D. L., Ribeiro, B. M. R. M., Serafim, M. S. M., Abrahão, J. S., & Ferreira, R. S. (2023) · Pharmaceuticals · doi:10.3390/ph16091319 · Cited by 10

Comparative Analysis of In Vitro Models to Study Antibody-Dependent Enhancement of Zika Virus Infection

Langerak, T., Mumtaz, N., Koopmans, M., Schoenmakers, S., & Rockx, B. (2022) · Viruses · doi:10.3390/v14122776 · Cited by 10

Immune Recognition versus Immune Evasion Systems in Zika Virus Infection

Chan, Y. T., Cheok, Y. Y., Cheong, H. C., Tang, T. F., Sulaiman, S., Hassan, J., Looi, C. Y., Tan, K., AbuBakar, S., & Wong, W. F. (2023) · Biomedicines · doi:10.3390/biomedicines11020642 · Cited by 10

Zika virus and diagnostics

Gabaglia, C. R. (2016) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000000446 · Cited by 10

Passive immunisation of convalescent human anti-Zika plasma protects against challenge with New World Zika virus in cynomolgus macaques

Berry, N. J., Kempster, S. L., Ham, C., Jenkins, A., Hall, J., Page, M., Mattiuzzo, G., Adedeji, Y., Hewson, R., Giles, E., et al. (2020) · npj Vaccines · doi:10.1038/s41541-020-00234-y · Cited by 10

Flavivirus Infection Associated with Cerebrovascular Events

Estofolete, C. F., Milhim, B. H. G. D. A., Zini, N., Scamardi, S. N., Selvante, J. D. S., Vasilakis, N., & Nogueira, M. L. (2020) · Viruses · doi:10.3390/v12060671 · Cited by 10

Microbial Infection as a Trigger of T-Cell Autoimmunity

Getts, D. R., Spiteri, A. G., King, N. J. C., & Miller, S. D. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-812102-3.00021-x · Cited by 9

A case study of Guillain-Barre syndrome associated with Zika virus infection

Soto‐Hernández, J. L., Carrillo-Loza, K., & Vargas‐Cañas, S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820267-8.00018-2

Zika virus infection complicated by Guillain-Barré syndrome – case report, French Polynesia, December 2013

Oehler, E., Watrin, L., Larre, P., Leparc-Goffart, I., Lastère, S., Valour, F., Baudouin, L., Mallet, H., Musso, D., & Ghawche, F. (2014) · Eurosurveillance · doi:10.2807/1560-7917.es2014.19.9.20720 · Cited by 1,046

Guillain–Barré Syndrome After Zika Virus Infection in Brazil

do Rosário, M. S., de Jesus, P. A. P., Vasilakis, N., Farias, D. S., Novaes, M. A. C., Rodrigues, S. G., Martins, L. C., Vasconcelos, P. F. D. C., Ko, A. I., Alcântara, L. C. J., et al. (2016) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.16-0306 · Cited by 99

Franklin Institute Awards Call for Nominations

(2021) · Journal of the Franklin Institute · doi:10.1016/s0016-0032(21)00390-2

Clinical manifestations and outcomes of Guillain-Barre syndrome complicating Zika virus infection

Alboudi, A. M., & Jameson, A. P. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820267-8.00019-4